Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study)
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This study compares low-dose prednisolone therapy against standard regimens of hydrocortisone
therapy for the treatment of adrenal insufficiency (AI). AI is a condition in which,
individuals are unable to sufficiently produce the natural stress hormone, cortisol.
Phase:
Phase 3
Details
Lead Sponsor:
Imperial College London
Collaborators:
Imperial College Healthcare Charity Imperial Health Charity National Institute for Health Research, United Kingdom